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between plasma vitamin A, vitamin E, serum coenzyme Q10 levels
and degree of insulin resistance in obese and normal weight
people. The study was performed on 98 (21 Male, 77 Female)
obese people and 78 (20 Male, 58 Female) control subjects. Vitamin
A, E and coenzyme Q10 levels were adjusted to the lipid levels.
Adjusted vitamin A and E and coenzyme Q10 levels of the obese
female group were significantly lower than those of the control
female group. Adjusted vitamin A and coenzyme Q10 levels of the
obese male group were significantly lower than those of the
control male group. Insulin resistance level of the obese female
and male groups were significantly higher than that of the control
female and male groups. There were no significant correlations
between serum coenzyme Q10, plasma vitamin A and E levels and
insulin resistance in obese and control subjects. Our findings show
that it is essential to use the lipid adjusted levels of lipid soluble
nutrients in obesity. Also, we have found no association between
insulin resistance and vitamin A, vitamin E and coenzyme Q10
levels in obese subjects.
Key Words: coenzyme Q10, vitamin A, vitamin E, insulin resistance, 
obesity
Introduction The prevalence of obesity has increased in world with a major
impact on public health because of its role as risk factor for
many diseases including cardiovascular disease and cancer,(1) with
a consequent reduction in life expectancy. Obesity has been
associated with low-grade inflammation,(2) playing a role in the
pathogenesis of insulin resistance(3) and cardiovascular risk(2,4) and
with oxidative stress, an imbalance between the production of
reactive oxygen species and antioxidant defences that is also
involved in the pathogenesis of cardivascular disease and cancer.(5)
The antioxidants α-tocopherol, the dominant component of
vitamin E, vitamin A and coenzyme Q10 (CoQ10) contribute to the
body’s defense agaist reactive oxygen species.(6–8) Epidemiologic
studies have consistently shown that higher intakes of vitamin A,
vitamin E and CoQ10 are associated with reduced risk of several
chronic diseases, including heart failure, age-related macular
degeneration and some cancers.(9,10) These micronutrients exhibit
multiple biological actions that may protect against disease. For
example, vitamin E is a chain breaking antioxidant that protect cell
membranes from damage caused by lipid peroxidation and also
inhibits cell proliferation and platelet adhesion.(9) Vitamin A is
essential for differentiation of epithelial cells and maintenance of
cell signaling and communication.(9) CoQ10 is well known for its
role as an electron transporter in the mitochondrial respiratory
chain. Also, CoQ10 is a powerful antioxidant even stronger than α-
tocopherol.(11,12)
The aim of the present study was to investigate correlation
between vitamin A, vitamin E, CoQ10 leves and homeostasis model
assesment (HOMA-IR) in obese and normal weight subjects.
Also, we examined associations of these parameters with body
mass index (BMI), waist circumference and waist-to-hip ratio in
the subjects.
Materials and Methods
Patients. This study was performed on 98 (21M, 77F) obese
people aged 18–65 years and 78 (20M, 58F) control subjects aged
18–65 years. There were no complaints and symptoms of the
obese subjects other than obesity. BMI was used as an obesity
criteria. BMI of the obese subjects was more than 30 kg/m2 and
that of healty controls was less than 25 kg/m2. Diatery patterns of
the subjects were estimated using a food questionnaire. Less than
5% of the obese and healty control participants reported tobacco
use. None of the subjects were taking a HMG-CoA reductase
inhibitor (statin) treatment and vitamin supplementation. The study
was approved by Hospital Ethics Committee, and informed
consent was obtained from all participants. Blood samples were
obtained from the subjects between 8 A.M. and 9 A.M. after a 12-
h overnight fast on plain and EDTA tubes. Plasma and sera of the
samples were separated and frozen at −80°C until the day of study
and thawed only once.
Anthropometric assessment. All anthropometric measure-
ment were made with participants wearing light clothing and no
shoes. BMI was measured in all participants. BMI was calculated
as weight (in kilograms) divided by height (in meters) squared,
and participants waists were measured with a soft tape midway
between the lowest rib and the iliac crest. The hip circumferences
was measured at the widest part of the gluteal region.
Sample analyses. Serum CoQ10 levels were measured using
the ImmuChrom reagent kit for high-performance liquid chroma-
tography (HPLC) technique with UV-detector. Plasma (in EDTA-
blood) vitamin A and vitamin E levels were measured using the
Chromsystems (Munich, Germany) reagent kit for HPLC technique
with UV-detector. Serum total cholesterol, triglycerides, high
density lipoprotein (HDL) cholesterol and blood glucose was
measured by commertially available kits based by routine methods
on the Synchron LX System (Beckman Coulter, Fullerton CA).
Low density lipoprotein (LDL) cholesterol was calculated using
the formula by Friedewald et al.(13) Insulin levels were determined
by routine chemiluminesans method on E170 analyzer (Roche
Diagnostics).
Calculations. HOMA-IR was used to detect the degree of
insulin resistance. The resistance can be assessed from the fasting
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blood glucose and insulin concentrations by the formulae:
HOMA-IR = insulin (mU/l) × glucose (mmol/l)/22.5
HOMA-IR scores greater than ≥2.5 shows low insulin sensitivity
(insulin resistance).(14,15) Adjusted vitamin A and vitamin E were
calculated as vitamin A/(total cholesterol + triglycerides) (μmol/
mmol) and vitamin E/(total cholesterol + triglycerides) (μmol/
mmol).
Statistical analysis. All data are expressed as mean ±
standard deviation (SD). Statistical analyses were done using
SPSS ver. 17.0 (SPSS Inc., IL). The normal distribution of vari-
ables were examined with Independent-Samples t test, and non-
normally distributed variables were examined by Mann-Whitney
U test. The correlations between variables were performed by
Pearson’s Correlation test. Differences were considered signifi-
cant at a probability level of p<0.05.
Results
Clinical and analytical characteristics of the obese and control
subjects are presented in Table 1. As seen, BMI, waist circum-
ference, waist-to-hip ratio, systolic and diastolic blood pressure,
triglycerides, fasting blood glucose, fasting blood insülin and
HOMA-IR values of the obese female and male subjects were
significantly higher than those of the controls (p<0.001). Total-
cholesterol and LDL-cholesterol of the obese female subjects
were significantly higher than those of the controls (p<0.001 for
total-cholesterol and p<0.01 for LDL-cholesterol) whereas HDL-
cholesterol level of obese female group was lower than that of the
control group (p<0.001). There were no significant differences
between total-cholesterol, LDL-cholesterol and HDL-cholesterol
levels of the male groups.
Vitamins and CoQ10 concentrations of the obese and the control
subjects are presented in Table 2. As seen, adjusted vitamin A
(p<0.001), adjusted vitamin E (p<0.05), CoQ10/total cholesterol
(p<0.05), CoQ10/LDL (p<0.05), CoQ10/triglyceride (p<0.001) and
CoQ10/total cholesterol + triglyceride (p<0.001) values of the obese
female subjects were significantly lower than those of the control
group. Adjusted vitamin A (p<0.05) and CoQ10/triglyceride (p<0.05)
values of the obese male subjects were significantly lower than
those of the control group.
Simple correlation analysis were performed to investigate the
association of plasma vitamins (adjusted and unadjusted) and
CoQ10 measures with BMI, waist circumference, waist-to-hip ratio,
age and HOMA-IR. As shown in Table 3, vitamin A (r = −0.222,
Table 1. Clinical and analytical characteristics of the control and the obese subjects
1 standart deviation. BMI, body mass index. HDL cholesterol, high density lipoprotein cholesterol. LDL cholesterol, low density lipoprotein cholesterol.
HOMA IR, homeostasis model assesment. *p<0.05, **p<0.01.
Control (mean ± SD1) Obese (mean ± SD1)
Female (n = 58) Male (n = 20) Female (n = 77) Male (n =2 1 )
Age (years) 36.15 ± 10.1 39.20 ± 14.4 37.65 ± 12.4 39.47 ± 14.1
BMI (kg/m2) 20.66 ± 2.4 22.10 ± 2.2 43.61 ± 6.4** 39.85 ± 6.0**
Waist circumference (cm) 71.15 ± 7.4 84.70 ± 5.3 117.85 ± 11.5** 123.85 ± 11.4**
Waist to hip ratio 0.74 ± 0.05 0.84 ± 0.03 0.84 ± 0.06** 0.95 ± 0.07**
Systolic blood pressure (mmHg) 110.13 ± 4.1 117.1 ± 2.8 130.13 ± 3.4** 137.13 ± 3.4**
Diastolic blood pressure (mmHg) 70.1 ± 2.5 73.4 ± 1.0 82.1 ± 3.0** 84.2 ± 2.4**
Total cholesterol (mmol/l) 4.62 ± 0.9 4.91 ± 0.9 5.14 ± 1.1** 5.0 ± 1.0
Triglycerides (mmol/l) 0.80 ± 0.4 1.23 ± 0.5 1.77 ± 1.0** 1.98 ± 0.9**
HDL cholesterol (mmol/l) 1.39 ± 0.3 1.01 ± 0.2 1.13 ± 0.2** 0.92 ± 0.2
LDL cholesterol (mmol/l) 2.86 ± 0.8 3.15 ± 1.0 3.19 ± 0.9* 3.34 ± 0.8
Fasting blood glucose (mg/dl) 84.11 ± 7.4 83.8 ± 10.6 99.81 ± 12.9** 100.1 ± 11.3**
Fasting blood insülin (μU/ml) 5.65 ± 2.7 6.26 ± 3.9 15.94 ± 8.4** 22.07 ± 11.7**
HOMA IR 1.16 ± 0.6 1.31 ± 0.9 3.75 ± 3.2** 4.64 ± 2.9**
Table 2. Vitamins and CoQ10 concentrations in the control and the obese subjects
1 standart deviation. CoQ10, coenzyme Q10. LDL, low density lipoprotein cholesterol. *p<0.05, **p<0.01.
Control (mean ± SD1) Obese (mean ± SD1)
Female (n = 58) Male (n = 20) Female (n = 77) Male (n = 21)
Vitamin A (retinol) (μmol/l) 1.84 ± 0.6 2.33 ± 0.5 2.01 ± 0.5 2.25 ± 0.5
Adjusted Vitamin A (μmol/mmol) 
(vitamin A/(total cholesterol + triglycerides))
0.34 ± 0.1 0.39 ± 0.1 0.29 ± 0.08** 0.32 ± 0.09*
Vitamin E (α tokoferol) (μmol/l) 30.46 ± 8.5 32.55 ± 8.3 33.47 ± 8.8 29.75 ± 8.1
Adjusted Vitamin E (μmol/mmol) 
(vitamin E/(total cholesterol + triglycerides))
5.53 ± 1.1 4.86 ± 0.9 5.07 ± 1.2* 4.67 ± 1.2
CoQ10 (μmol/l) 1.58 ± 0.7 1.46 ± 0.5 1.49 ± 0.6 1.38 ± 0.4
CoQ10/total cholesterol (μmol/mmol) 0.34 ± 0.1 0.29 ± 0.1 0.29 ± 0.1* 0.27 ± 0.07
CoQ10/LDL (μmol/mmol) 0.58 ± 0.3 0.44 ± 0.1 0.48 ± 0.2* 0.47 ± 0.1
CoQ10/triglycerides (μmol/mmol) 2.50 ± 2.0 1.28 ± 0.5 1.05 ± 0.6** 0.89 ± 0.5*
CoQ10/(total cholesterol + triglycerides) 
(μmol/mmol)
0.30 ± 0.1 0.024 ± 0.08 0.22 ± 0.08** 0.20 ± 0.05 J. Clin. Biochem. Nutr. | November 2011 | vol. 49 | no. 3 | 161
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p<0.05) and adjusted vitamin A (r = −0.269, p<0.01) levels were
negatively correlated with BMI and adjusted vitamin A was
negatively correlated with waist circumference (r = −0.202,
p<0.05) in obese group. Vitamin A was positively correlated with
age (r = 0.258, p<0.05) in obese group.
Adjusted vitamin E was negatively correlated with BMI (r =
−0.237, p<0.05), waist circumference (r = −0.380, p<0.01) and
waist-to-hip ratio (r = −0.271, p<0.05) in control group (Table 4).
On the other hand, adjusted vitamin E was negatively correlated
with waist circumference (r = −0.233, p<0.05), waist-to-hip ratio
(r = −0.273,  p<0.01) in obese group. Furthermore, vitamin E
(r = 0.246, p<0.05) was positively correlated with age in obese
group.
CoQ10 was positively correlated with age (r = 0.240, p<0.05)
in obese group. CoQ10/total cholesterol ratio was negatively
correlated with age (r = −0.228, p<0.05) in control group (Table 5).
CoQ10/LDL ratio was negatively correlated with waist circum-
ference (r = −0.337,  p<0.01), waist-to-hip ratio (r = –0.285,
p<0.05) and age (r = −0.295, p<0.01) in the control group. CoQ10/
triglyceride ratio was negatively correlated with waist circum-
ference (r = −0.387,  p<0.01), waist-to-hip ratio (r = −0.285,
p<0.05) in the control group. CoQ10/total cholesterol + triglyceride
ratio was negatively correlated with waist circumference (r =
−0.281, p<0.01), waist-to-hip ratio (r = −0.250, p<0.05) and age
(r = −0.233, p<0.05) in the control group.
CoQ10 was positively correlated with vitamin E in obese group
(r = 0.272, p<0.01) (data not shown). On the other hand, there
were no correlations between HOMA-IR values and adjusted and
unadjusted vitamin E, vitamin A and CoQ10 levels in the obese and
the control subjects.
Discussion
In the present study, adjusted serum vitamin E concentration
was significantly higher in the obese female group than in the
control group. However, there was no significant difference
between unadjusted vitamin E levels of the groups. Also, there
was no correlation between unadjusted vitamin E levels and BMI
while adjusted vitamin E level was negatively correlated with
BMI in the control group and waist circumference and waist-to-
hip ratio in the obese and the control group. Since vitamin E is
transported in lipoprotein particules we believe that it is more
accurate to use the lipid-adjusted vitamine E levels to evaluate
vitamine E status of the obese subjects. Indeed, it has been
reported that the strongest and most consistent predictor of all
serum fat-soluble nutrients were serum cholesterol.(6,16,17)
In the literature, there are conflicting findings about the correla-
tion of vitamin E levels with obesity. For example, adjusted(18) and
unadjusted(5,9,19,20) plasma vitamin E level was found to be
negatively associated with BMI. In contrast, adjusted vitamin E
level was not associated in one study(21) and positively associated
with BMI in another study.(6)
We believe that the reason for the differences between these
findings is the usage of the adjusted and unadjusted levels of
Table 3. Correlations of plasma vitamin A and adjusted vitamin A levels with clinical and biochemical variables of the control and the obese subjects
BMI, body mass index. HOMA IR, homeostasis model assesment. *p<0.05, **p<0.01.
Control (n = 78) Obese (n =9 8 )
Vitamin A Adjusted vitamin A Vitamin A Adjusted vitamin A
BMI 0.132 –0.085 –0.222* –0.269**
Waist circumference 0.336 0.060 –0.161 –0.202*
Waist to hip ratio 0.320 0.082 –0.019 –0.059
HOMA IR 0.148 0.135 0.073 0.092
Table 4. Correlations of plasma vitamin E and adjusted vitamin E levels with clinical and biochemical variables of the control and the obese subjects
BMI, body mass index. HOMA IR, homeostasis model assesment. *p<0.05, **p<0.01.
Control (n = 78) Obese (n =9 8 )
Vitamin E Adjusted vitamin E Vitamin E Adjusted vitamin E
BMI 0.068 –0.237* 0.095 –0.044
Waist circumference 0.060 –0.380** 0.047 –0.233*
Waist to hip ratio 0.080 –0.271* –0.121 –0.273**
HOMA IR –0.082 –0.130 0.134 –0.003
Table 5. Correlations of serum CoQ10 levels with clinical and biochemical variables of the control and the obese subjects
BMI, body mass index. LDL cholesterol, low density lipoprotein cholesterol. HOMA IR, homeostasis model assesment. CoQ10, coenzyme Q10. *p<0.05,
**p<0.01.
Control Obese
BMI Waist 
circumference
Waist to hip 
ratio Age HOMA IR BMI Waist 
circumference
Waist to hip 
ratio Age HOMA IR
CoQ10 0.110 –0.065 –0.050 –0.151 0.065 0.140 0.085 0.101 0.240* –0.016
CoQ10/total cholesterol –0.026 –0.217 –0.185 –0.228* 0.054 0.142 0.067 0.095 0.126 –0.063
CoQ10/LDL –0.147 –0.337** –0.285* –0.295** 0.057 0.168 0.083 0.084 0.111 –0.050
CoQ10/triglyceride –0.155 –0.387** –0.285* –0.211 –0.060 –0.097 –0.089 –0.022 0.111 –0.055
CoQ10/total cholesterol 
+ triglyceride
–0.059 –0.281* –0.250* –0.233* 0.017 0.064 0.003 0.049 0.108 –0.047doi: 10.3164/jcbn.11 08
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the vitamin. Another reason might be the differences between the
degree of obesity, age and dietary habituate of the investigated
subjects.
In our study there was no significant difference between
unadjusted plasma vitamin A levels of the obese and control
subjects. However, adjusted vitamin A level of the obese female
and male subjects was significantly lower than that of the control
group. Also, adjusted vitamin A level was negatively correlated
with BMI and waist circumference in the obese group. Since
retinol is considered an antioxidant and anti-inflammatory
agent(22,23) our results suggest that obesity is associated with a
lesser capacity of anti-inflammatory and antioxidant potential.
Although there are some conflicting findings concerning plasma
vitamin A levels of obese subjects, generally the findings of the
other investigors are in consisting with our findings. For example,
Viroonudomphol  et al.(19) have found a negative correlation
between serum unadjusted retinol and BMI, waist-hip circum-
ferences in both overweight and obese subjets. Botella-Carretero
et al.(5) have found a negative correlation of serum unadjusted
retinol with BMI in morbid obese people. Neuhouser et al.(9) have
found that obesity was associated with low serum unadjusted
retinol concentration. Switzer et al.(21) have reported that plasma
adjusted retinol concentrations was not associated with BMI in
older African American women.
The present study demonstrated that there was no difference
between unadjusted plasma CoQ10 levels of the obese female and
male subjects and the control subjects. However, lipid adjusted
CoQ10 levels were significantly lower in the obese female and
male subjects than in the controls. Since, CoQ10 is a powerful
antioxidant, our lipid adjusted CoQ10 levels show that there is an
antioxidant defficiency in obese subjects.
Mancini et al.(15) have found no difference between unadjusted
plasma CoQ10 levels of obese and control subjects. Also, Menke
et al.(14) have found that unadjusted plasma CoQ10 levels of obese
and normal weight children were not different. Butler et al.(24) have
reported that unadjusted plasma CoQ10 level was significantly
lower in obese subjects than in control subjects. Since, CoQ is
transported in lipoproteins, it is clear that lipid-corrected levels are
more informative. Therefore, we believe that our results provide
more accurate information about CoQ status of the obese subjects.
On the other hand, CoQ10 originates from endogenous synthesis
as well as from food intake.(14) Therefore, the ethnic difference in
lifestyle and nutritional patterns may result in differences in
plasma CoQ10 levels found in different studies.(25)
In this study, both unadjusted plasma CoQ10 and unadjusted
vitamin E levels positively correlated to cholesterol, triglycerides
and HDL concentrations in the obese subjects. Also, unadjusted
plasma CoQ10 levels were positively correlated to unadjusted
vitamin E in obese people (data not shown). This may indicate
that vitamine E and endogenous CoQ10 synthesis may compensate
the greater demand of lipophilic antioxidants in the plasma in
situations like obesity where plasma lipids are increased.(26–28)
Both vitamin E and CoQ10 possess distinct lipoprotective
antioxidant properties in biological membranes. Their combined
antioxidant activity, however, is markedly synergistic when both
are present together.(26) These data provide direct evidence for an
interactive effect between vitamin E and CoQ10 in obese people.
In our study, we have found no correlation between HOMA-IR,
CoQ10, vitamin A and E values in both the obese and the control
subjects. Botella-Carretero et al.(5) have found no correlation
between HOMA-IR and unadjusted plasma vitamin A and E levels
in obese subjects, a finding which supports our findings. We have
found no study investigating an asociation between (adjusted/
unadjusted) CoQ10 levels and HOMA-IR values in obese subjects.
Therefore, our study is the first one investigating such a correla-
tion.
As seen from our data (Table 2), the findings of the obese
female and the control female are different from those of the
findings of the obese male and the control male. Although the
underlying mechanism of these differences are not known we
believe that this may be due to metabolic differences between
male and female subjects and the lower number of male subjects in
our study.
In conclusion, our findings show that lipid-adjusted vitamin A,
E and CoQ10 levels of the obese subjects were significantly lower
than those of the controls. Also, we have found no association
between HOMA-IR and vitamin A, E and CoQ10 levels in the
obese subjects.
Abbreviations
BMI body mass index
CoQ10 coenzyme Q10
HDL high density lipoprotein
HOMA-IR homeostasis model assesment
HPLC high-performance liquid chromatography
LDL low density lipoprotein
SD standard deviation
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